ClinicalTrials.gg
CompletedNCT02878226Updated Jun 27, 2018

Outcomes of Uterine Rupture

An observational study in Maternal Mortality, sponsored by Assiut University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2018-06-27.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
65
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

Uterine rupture (UR) is a serious, life-threatening obstetric complication. UR is associated with an increased risk of maternal and perinatal morbidity and mortality, particularly in developing countries compared to developed countries. UR occurs mainly as a consequence of poorly managed labour

02

Conditions studied

  • Maternal Mortality

Browse trials for

03

In context

Maternal Death

77 studies on the registry are indexed under Maternal Death; 19 are open to participants now.

This study's enrollment of 65 is below the median of 180 across 19 observational studies indexed under Maternal Death.

Browse Maternal Death studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients presented with clinical symptoms and signs of rupture uterus, whatever the duration of pregnancy, and the diagnosis proved on surgical exploration to be a case of rupture uterus

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women with ruptured uterus
  • accept to share in the study

Exclusion criteria

Exclusion Criteria:

  • women refuse to participate
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
65 participants (actual)
Patient registry
No

Interventions

  • Procedurerepair of rupture
06

What researchers measure

Primary outcomes

  1. number of women undergoes repair

    Time frame: 1 hour

07

Study locations

1 site
  • Ahmed Abbas
    Assiut, Cairo 002, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2016 to primary completion in Dec 2017, 16 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2016
First posted
Aug 25, 2016
StartActual
Aug 2016
Primary completionActual
Dec 15, 2017
CompletionActual
Feb 18, 2018
Last update
Jun 27, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02878226
Lead sponsor
Assiut University
Responsible party
Ahmed Mohamed Abbas (Dr, Assiut University) — Principal investigator
First posted
Aug 25, 2016
Start date
Aug 2016
Primary completion
Dec 15, 2017
Completion
Feb 18, 2018
Last update
Jun 27, 2018

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion